TrialClinical cancer research : an official journal of the American Association for Cancer Research2026

Efficacy and Genomic Analysis of HER2-Mutant Metastatic Triple-Negative Breast Cancer Treated with Neratinib Alone or with Trastuzumab in the SUMMIT Basket Trial.

Komal Jhaveri et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.